Skip to main content Help with accessibility Skip to main navigation

Liothyronine

Indication

Add-on treatment for refractory hypothyroidism in secondary care – existing patients.

Grey

Brand:

Nice TA:

Commissioning responsibility:

CCG

PbR excluded:

No

BNF chapter:
Endocrine system

Background

Liothyronine is recommended for limited use in secondary care for patients with established benefit from the addition of liothyronine where disease stabilisation was unachievable with levothyroxine alone.

Recommendation

LSCMMG Recommendation:

Grey

Reason for decision:

Prioritised for review

Supporting documents:

Decisions of Lancashire local decision making groups

Pending
Pending
Pending
Pending
Pending
Pending
Pending
Pending
What do the colours mean?

Last Updated: 20 - May - 2021